Sintx Technologies (SINT) Net Shares Issued and Repurchased (2014 - 2026)
Sintx Technologies (SINT) posted Net Shares Issued and Repurchased of $106.5 million for Q1 2026, up 1182799900.0% on a QoQ basis from $9.0 in Q4 2025, and up 10645199900.0% year-over-year from N/an in Q1 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends
Sintx Technologies has reported Net Shares Issued and Repurchased for 13 years, with the latest figure at $106.5 million in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 10645199900.0% year-over-year to $106.5 million in Q1 2026; TTM through Mar 2026 was $106.5 million, a 10645199900.0% increase from a year earlier, with the FY2025 full-year figure at $9.0, down 99.96% from the prior year.
- Net Shares Issued and Repurchased was $106.5 million for Q1 2026 at Sintx Technologies, up from $9.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $106.5 million in Q1 2026, with the low at $1.0 in Q1 2025.
- Average Net Shares Issued and Repurchased over 5 years is $15.2 million, with a median of $3550.0 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Net Shares Issued and Repurchased tumbled 99.97% in 2025, then soared 10645199900.0% in 2026.
- Over 5 years, Net Shares Issued and Repurchased stood at $3.0 in 2022, then jumped by 118266.67% to $3551.0 in 2023, then soared by 575.87% to $24000.0 in 2024, then plunged by 99.96% to $9.0 in 2025, then surged by 1182799900.0% to $106.5 million in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $106.5 million (Q1 2026), $9.0 (Q4 2025), and $1.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 106.45 Mn |
| Dec 31, 2025 | 9.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 3,550.00 |
| Mar 31, 2023 | 3,551.00 |
| Mar 31, 2022 | 3.00 |
| Dec 31, 2021 | 1.00 |
| Dec 31, 2020 | 1.00 |
| Mar 31, 2019 | 11.00 |
| Dec 31, 2018 | 1.00 |
| Dec 31, 2017 | 144.00 |
| Mar 31, 2017 | 14.00 |
| Dec 31, 2016 | 1,198.00 |
| Mar 31, 2016 | -13,702.00 |
| Dec 31, 2015 | 5,871.00 |
| Dec 31, 2014 | 157,102.00 |
| Mar 31, 2014 | 19,847.00 |